Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. - Owen-Schaub,L.B.; Radinsky,R.; Kruzel,E.; Berry,K.; Yonehara,S. (Cancer Res, 1994)